Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3

References

• Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, Jose PA, Taylor SI, Westphal H. 1996. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet. 12:106–109.
   PubMed Web of Science ®Google Scholar
• Adams TE, Epa VC, Garrett TP, Ward CW. 2000. Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci. 57:1050–1093.
   PubMed Web of Science ®Google Scholar
• Ahmad T, Farnie G, Bundred NJ, Anderson NG. 2004. The mitogenic action of insulin-like growth factor I in normal human mammary epithelial cells requires the epidermal growth factor receptor tyrosine kinase. J Biol Chem. 279:1713–1719.
   PubMed Web of Science ®Google Scholar
• Baserga R. 1995. The insulin-like growth factor I receptor: A key to tumor growth?. Cancer Res. 55:249–252.
   PubMed Web of Science ®Google Scholar
• Baxter RC. 2000. Insulin-like growth factor (IGF) binding proteins: Interactions with IGFs and intrinsic bioactivities. Am J Physiol. 278:E967–E976.
   PubMed Web of Science ®Google Scholar
• Beattie J, Phillips K, Shand JH, Szymanowska M, Flint DJ, Allan GJ. 2008. Molecular interactions in the insulin-like growth factor (IGF) axis: A surface plasmon resonance (SPR) based biosensor study. Mol Cell Biochem. 307:221–236.
   PubMed Web of Science ®Google Scholar
• Beattie J, Kreiner M, Allan GJ, Flint DJ, Domingues D, van der Walle CF. 2009. IGFBP-3 and IGFBP-5 associate with the cell binding domain (CBD) of fibronectin. Biochem Biophys Res Commun. 381:572–576.
   PubMed Web of Science ®Google Scholar
• Beattie J, McIntosh L, van der Walle CF. 2010. Cross-talk between the insulin-like growth factor (IGF) axis and membrane integrins to regulate cell physiology. J Cell Physiol. 224:605–611.
   PubMed Web of Science ®Google Scholar
• Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. 2009. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev. 30:586–623.
   PubMed Web of Science ®Google Scholar
• Binoux M, Lalou C, Lassarre C, Blat C, Hossenlopp P. 1993. Limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3): A physiological mechanism in the regulation of IGF bioavailability. Adv Exp Med Biol. 343:293–300.
   PubMedGoogle Scholar
• Buck E, Eyzaguirre A, Rosenfeld-Franklin M, Thomson S, Mulvihill M, Barr S, Brown E, O'Connor M, Yao Y, Pachter J, Miglarese M, Epstein D, Iwata KK, Haley JD, Gibson NW, Ji Q-S. 2008. Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors. Cancer Res. 68:8322–8332.
   PubMed Web of Science ®Google Scholar
• Bunn RC, Fowlkes JL. 2003. Insulin-like growth factor binding protein proteolysis. Trends Endocrinol Metab. 14:176–181.
   PubMed Web of Science ®Google Scholar
• Butt AJ, Martin JL, Dickson KA, McDougall F, Firth SM, Baxter RC. 2004. Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: The role of altered epidermal growth factor signaling. J Clin Endocrinol Metab. 89:1950–1956.
   PubMed Web of Science ®Google Scholar
• Cabello-Verrugio C, Brandan E. 2007. A novel modulatory mechanism of transforming growth factor-beta signaling through decorin and LRP-1. J Biol Chem. 282:18842–18850.
   PubMed Web of Science ®Google Scholar
• Canonici A, Steelant W, Rigot V, Khomitch-Baud A, Boutaghou-Cherid H, Bruyneel E, Van Roy F, Garrouste F, Pommier G, Andre F. 2008. Insulin-like growth factor-I receptor, E-cadherin and alpha v integrin form a dynamic complex under the control of alpha-catenin. Int J Cancer. 122:572–582.
   PubMed Web of Science ®Google Scholar
• Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, Fiorentino R, Varricchio L, Barone MV, Auricchio F. 2001. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 20:6050–6059.
   PubMed Web of Science ®Google Scholar
• Chan SS, Schedlich LJ, Twigg SM, Baxter RC. 2009. Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3. Am J Physiol Endocrinol Metab. 296:E654–E663.
   PubMed Web of Science ®Google Scholar
• Clemmons DR, Maile LA. 2003. Minireview: Integral membrane proteins that function coordinately with the insulin-like growth factor I receptor to regulate intracellular signaling. Endocrinology. 144:1664–1670.
   PubMed Web of Science ®Google Scholar
• Clemmons DR, Maile LA. 2005. Interaction between insulin-like growth factor-I receptor and αVβ3 integrin linked signaling pathways: Cellular responses to changes in multiple signaling inputs. Mol Endocrinol. 19:1–11.
   PubMed Web of Science ®Google Scholar
• Daughaday WH, Trivedi B, Baxter RC. 1993. Serum “big insulin-like growth factor II” from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. Proc Natl Acad Sci USA. 90:5823–5827.
   PubMed Web of Science ®Google Scholar
• De Meyts P, Christoffersen CT, Ursø B, Wallach B, Grønskov K, Yakushiji F, Shymko RM. 1995. Role of the time factor in signaling specificity: Application to mitogenic and metabolic signaling by the insulin and insulin-like growth factor-I receptor tyrosine kinases. Metabolism. 44:2–11.
   PubMed Web of Science ®Google Scholar
• Denley A, Brierley GV, Carroll JM, Lindenberg A, Booker GW, Cosgrove LJ, Wallace JC, Forbes BE, Roberts CTJr. 2006. Differential activation of insulin receptor isoforms by insulin-like growth factors is determined by the C domain. Endocrinology. 147:1029–1036.
   PubMed Web of Science ®Google Scholar
• Dupont J, Khan J, Qu BH, Metzler P, Helman L, LeRoith D. 2001. Insulin and IGF-1 induce different patterns of gene expression in mouse fibroblast NIH-3T3 cells: Identification by cDNA microarray analysis. Endocrinology. 142:4969–4975.
   PubMed Web of Science ®Google Scholar
• Dupont J, Pierre A, Froment P, Moreau C. 2003. The insulin-like growth factor axis in cell cycle progression. Horm Metab Res. 35:740–750.
   PubMed Web of Science ®Google Scholar
• El-Shewy HM, Lee MH, Obeid LM, Jaffa AA, Luttrell LM. 2007. The insulin-like growth factor type 1 and insulin-like growth factor type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells. J Biol Chem. 282:26150–26157.
   PubMed Web of Science ®Google Scholar
• Fanayan S, Firth SM, Butt AJ, Baxter RC. 2000. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-β) and the type II TGF-β receptor. J Biol Chem. 275:39146–39151.
   PubMed Web of Science ®Google Scholar
• Fanayan S, Firth SM, Baxter RC. 2002. Signaling through the Smad pathway by insulin-like growth factor binding protein-3 in breast cancer cells: Relationship to transforming growth factor-β1 signaling. J Biol Chem. 277:7255–7261.
   PubMedGoogle Scholar
• Firth SM, Baxter RC. 2002. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 23:824–854.
   PubMed Web of Science ®Google Scholar
• Forbes K, Souquet B, Garside R, Aplin JD, Westwood M. 2010. Transforming growth factor-β (TGFβ) receptors I/II differentially regulate TGFβ1 and IGF-binding protein-3 mitogenic effects in the human placenta. Endocrinology. 151:1723–1731.
   PubMed Web of Science ®Google Scholar
• Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A, Vigneri R. 1999. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol. 19:3278–3288.
   PubMed Web of Science ®Google Scholar
• Gallagher EJ, LeRoith D. 2010. The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab. 21:610–618.
   PubMed Web of Science ®Google Scholar
• Granata R, Trovato L, Garbarino G, Taliano M, Ponti R, Sala G, Ghidoni R, Ghigo E. 2004. Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: Involvement of the sphingolipid signaling pathways. FASEB J. 18:1456–1458.
   PubMed Web of Science ®Google Scholar
• Guix M, Faber AC, Wang SE, Olivares MG, Song Y, Qu S, Rinehart C, Seidel B, Yee D, Arteaga CL, Engelman JA. 2008. Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins. J Clin Invest. 118:2609–2619.
   PubMed Web of Science ®Google Scholar
• Hansen BF, Danielsen GM, Drejer K, Sørensen AR, Wiberg FC, Klein HH, Lundemose AG. 1996. Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency. Biochem J. 315:271–279.
   PubMed Web of Science ®Google Scholar
• Hermanto U, Zong CS, Li W, Wang LH. 2002. RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix. Mol Cell Biol. 22:2345–2365.
   PubMed Web of Science ®Google Scholar
• Hollier BG, Kricker JA, Van Lonkhuyzen DR, Leavesley DI, Upton Z. 2008. Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-Vn-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by alphav-integrins and the IGF-I receptor. Endocrinology. 149:1075–1090.
   PubMed Web of Science ®Google Scholar
• Huang SS, Ling TY, Tseng WF, Huang YH, Tang FM, Leal SM, Huang JS. 2003. Cellular growth inhibition by IGFBP-3 and TGF-beta1 requires LRP-1. FASEB J. 17:2068–2081.
   PubMed Web of Science ®Google Scholar
• Huang SS, Leal SM, Chen CL, Liu IH, Huang JS. 2004. Identification of insulin receptor substrate proteins as key molecules for the TbetaR-V/LRP-1-mediated growth inhibitory signaling cascade in epithelial and myeloid cells. FASEB J. 18:1719–1721.
   PubMed Web of Science ®Google Scholar
• Huynh H, Nickerson T, Pollak M, Yang X. 1996. Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780. Clin Cancer Res. 2:2037–2042.
   PubMed Web of Science ®Google Scholar
• Ikezoe T, Tanosaki S, Krug U, Liu B, Cohen P, Taguchi H, Koeffler HP. 2004. Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells. Blood. 104:237–242.
   PubMed Web of Science ®Google Scholar
• Ingermann AR, Yang YF, Han J, Mikami A, Garza AE, Mohanraj L, Fan L, Idowu M, Ware JL, Kim HS, Lee DY, Oh Y. 2010. Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer. J Biol Chem. 285:30233–30246.
   PubMed Web of Science ®Google Scholar
• Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, Grohe C. 2000. Estrogen Receptor α Rapidly Activates the IGF-1 Receptor Pathway. J Biol Chem. 275:18447–18453.
   PubMed Web of Science ®Google Scholar
• Kato H, Faria TN, Stannard B, Roberts CTJr, LeRoith D. 1994. Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action. Mol Endocrinol. 8:40–50.
   PubMed Web of Science ®Google Scholar
• Kielczewski JL, Jarajapu YP, McFarland EL, Cai J, Afzal A, Li Calzi S, Chang KH, Lydic T, Shaw LC, Busik J, Hughes J, Cardounel AJ, Wilson K, Lyons TJ, Boulton ME, Mames RN, Chan-Ling T, Grant MB. 2009. Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation. Circ Res. 105:897–905.
   PubMed Web of Science ®Google Scholar
• Kohanski RA. 1993. Insulin receptor autophosphorylation. II. Determination of autophosphorylation sites by chemical sequence analysis and identification of the juxtamembrane sites. Biochemistry. 32:5773–5780.
   PubMed Web of Science ®Google Scholar
• Kuemmerle JF, Murthy KS, Bowers JG. 2004. IGFBP-3 activates TGF-beta receptors and directly inhibits growth in human intestinal smooth muscle cells. Am J Physiol Gastrointest Liver Physiol. 287:G795–G802.
   Web of Science ®Google Scholar
• Laviola L, Natalicchio A, Giorgino F. 2007. The IGF-I signaling pathway. Curr Pharm Des. 13:663–669.
   PubMed Web of Science ®Google Scholar
• Lawrence MC, McKern NM, Ward CW. 2007. Insulin receptor structure and its implications for the IGF-1 receptor. Curr Opin Struct Biol. 17:699–705.
   PubMed Web of Science ®Google Scholar
• Leal SM, Liu Q, Huang SS, Huang JS. 1997. The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor. J Biol Chem. 272:20572–20576.
   PubMed Web of Science ®Google Scholar
• Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D. 1999. Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol. 13:787–796.
   PubMed Web of Science ®Google Scholar
• Lee KW, Ma L, Yan X, Liu B, Zhang XK, Cohen P. 2005. Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77. J Biol Chem. 280:16942–16948.
   PubMed Web of Science ®Google Scholar
• Lee SH, Takahashi M, Honke K, Miyoshi E, Osumi D, Sakiyama H, Ekuni A, Wang X, Inoue S, Gu J, Kadomatsu K, Taniguchi N. 2006. Loss of core fucosylation of low-density lipoprotein receptor-related protein-1 impairs its function, leading to the upregulation of serum levels of insulin-like growth factor-binding protein 3 in Fut8-/- mice. J Biochem. 139:391–398.
   PubMed Web of Science ®Google Scholar
• Lee KW, Cobb LJ, Paharkova-Vatchkova V, Liu B, Milbrandt J, Cohen P. 2007. Contribution of the orphan nuclear receptor Nur77 to the apoptotic action of IGFBP-3. Carcinogenesis. 28:1653–1658.
   PubMed Web of Science ®Google Scholar
• Lee YC, Jogie-Brahim S, Lee DY, Han J, Harada A, Murphy LJ, Oh Y. 2011. Insulin-like growth factor-binding protein-3 (IGFBP-3) blocks the effects of asthma by negatively regulating NF-kappaB signaling through IGFBP-3R-mediated activation of caspases. J Biol Chem. 286:17898–17909.
   PubMed Web of Science ®Google Scholar
• Lillis AP, Van Duyn LB, Murphy-Ullrich JE, Strickland DK. 2008. LDL receptor-related protein 1: Unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev. 88:887–918.
   PubMed Web of Science ®Google Scholar
• Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 75:59–72.
   PubMed Web of Science ®Google Scholar
• Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, Cohen P. 2000. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem. 275:33607–33613.
   PubMed Web of Science ®Google Scholar
• Maile LA, Clemmons DR. 2002. The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor. Endocrinology. 143:4259–4264.
   PubMed Web of Science ®Google Scholar
• Marks AG, Carroll JM, Purnell JQ, Roberts CTJr. 2011. Plasma distribution and signaling activities of IGF-II precursors. Endocrinology. 152:922–930.
   PubMed Web of Science ®Google Scholar
• Martin MB, Franke TF, Stoica GE, Chambon P, Katzenellenbogen BS, Stoica BA, McLemore MS, Olivo SE, Stoica A. 2000. A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology. 141:4503–4511.
   PubMed Web of Science ®Google Scholar
• Martin JL, Weenink SM, Baxter RC. 2003. Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinases. J Biol Chem. 278:2969–2976.
   PubMed Web of Science ®Google Scholar
• Martin JL, Lin MZ, McGowan EM, Baxter RC. 2009. Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity. J Biol Chem. 284:25542–25552.
   PubMed Web of Science ®Google Scholar
• Morelli C, Garofalo C, Bartucci M, Surmacz E. 2003. Estrogen receptor-[alpha] regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells. Oncogene. 22:4007–4016.
   PubMed Web of Science ®Google Scholar
• Morgillo F, Woo JK, Kim ES, Hong WK, Lee H-Y. 2006. Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of Erlotinib. Cancer Res. 66:10100–10111.
   PubMed Web of Science ®Google Scholar
• Navarro M, Baserga R. 2001. Limited redundancy of survival signals from the type 1 insulin-like growth factor receptor. Endocrinology. 142:1073–1081.
   PubMed Web of Science ®Google Scholar
• Neuenschwander S, Schwartz A, Wood TL, Roberts CJ, Henninghausen L, LeRoith D. 1996. Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin Invest. 97:2225–2232.
   PubMed Web of Science ®Google Scholar
• O'Connor R, Kauffmann-Zeh A, Liu Y, Lehar S, Evan GI, Baserga R, Blattler WA. 1997. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol Cell Biol. 17:427–435.
   PubMed Web of Science ®Google Scholar
• Pandini G, Medico E, Conte E, Sciacca L, Vigneri R, Belfiore A. 2003. Differential gene expression induced by insulin and insulin-like growth factor-II through the insulin receptor isoform A. J Biol Chem. 278:42178–42189.
   PubMed Web of Science ®Google Scholar
• Payet LD, Firth SM, Baxter RC. 2004. The role of the acid-labile subunit in regulating insulin-like growth factor transport across human umbilical vein endothelial cell monolayers. J Clin Endocrinol Metab. 89:2382–2389.
   PubMed Web of Science ®Google Scholar
• Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B, Baserga R. 1999. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol. 19:7203–7215.
   PubMed Web of Science ®Google Scholar
• Riedemann J, Takiguchi M, Sohail M, Macaulay VM. 2007. The EGF receptor interacts with the type 1 IGF receptor and regulates its stability. Biochem Biophys Res Commun. 355:707–714.
   PubMed Web of Science ®Google Scholar
• Rocha RL, Hilsenbeck SG, Jackson JG, Lee AV, Figueroa JA, Yee D. 1996. Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: Detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst. 88:601–606.
   PubMed Web of Science ®Google Scholar
• Roudabush FL, Pierce KL, Maudsley S, Khan KD, Luttrell LM. 2000. Transactivation of the EGF receptor mediates IGF-1-stimulated shc phosphorylation and ERK1/2 activation in COS-7 cells. J Biol Chem. 275:22583–22589.
   PubMed Web of Science ®Google Scholar
• Russo VC, Schutt BS, Andaloro E, Ymer SI, Hoeflich A, Ranke MB, Bach LA, Werther GA. 2005. Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion. Endocrinology. 146:4445–4455.
   PubMed Web of Science ®Google Scholar
• Saegusa J, Yamaji S, Ieguchi K, Wu C-Y, Lam KS, Liu F-T, Takada YK, Takada Y. 2009. The direct binding of insulin-like growth factor-1 (IGF-1) to integrin alphaVbeta3 is involved in IGF-1 signaling. J Biol Chem. 284:24106–24114.
   PubMed Web of Science ®Google Scholar
• Samani AA, Yakar S, LeRoith D, Brody P. 2007. The role of the IGF system in cancer growth and metastasis: Overview and recent insights. Endocr Rev. 28:20–47.
   PubMed Web of Science ®Google Scholar
• Schedlich LJ, Graham LD, O'Han MK, Muthukaruppan A, Yan X, Firth SM, Baxter RC. 2007. Molecular basis of the interaction between IGFBP-3 and retinoid X receptor: Role in modulation of RAR-signaling. Arch Biochem Biophys. 465:359–369.
   PubMed Web of Science ®Google Scholar
• Schedlich LJ, Muthukaruppan A, O'Han MK, Baxter RC. 2007. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts. Mol Endocrinol. 21:2378–2390.
   PubMedGoogle Scholar
• Scott CD, Firth SM. 2004. The role of the M6P/IGF-II receptor in cancer: Tumor suppression or garbage disposal?. Horm Metab Res. 36:261–271.
   PubMed Web of Science ®Google Scholar
• Sheen-Chen SM, Zhang H, Huang CC, Tang RP. 2009. Insulin-like growth factor-binding protein-3 in breast cancer: Analysis with tissue microarray. Anticancer Res. 29:1131–1135.
   PubMed Web of Science ®Google Scholar
• Sitar T, Popowicz GM, Siwanowicz I, Huber R, Holak TA. 2006. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Proc Natl Acad Sci USA. 103:13028–13033.
   PubMed Web of Science ®Google Scholar
• Song RXD, McPherson RA, Adam L, Bao Y, Shupnik M, Kumar R, Santen RJ. 2002. Linkage of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation. Mol Endocrinol. 16:116–127.
   PubMed Web of Science ®Google Scholar
• Soos MA, Whittaker J, Lammers R, Ullrich A, Siddle K. 1990. Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. Biochem J. 270:383–390.
   PubMed Web of Science ®Google Scholar
• Stull MA, Richert MM, Loladze AV, Wood TL. 2002. Requirement for IGF-I in epidermal growth factor-mediated cell cycle progression of mammary epithelial cells. Endocrinology. 143:1872–1879.
   PubMed Web of Science ®Google Scholar
• Swantek JL, Baserga R. 1999. Prolonged activation of ERK2 by epidermal growth factor and other growth factors requires a functional insulin-like growth factor 1 receptor. Endocrinology. 140:3163–3169.
   PubMed Web of Science ®Google Scholar
• Tai Y-T, Podar K, Catley L, Tseng Y-H, Akiyama M, Shringarpure R, Burger R, Hideshima T, Chauhan D, Mitsiades N, Richardson P, Munshi NC, Kahn CR, Mitsiades C, Anderson KC. 2003. Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3’-kinase/AKT signaling. Cancer Res. 63:5850–5858.
   PubMed Web of Science ®Google Scholar
• Thomson S, Petti F, Sujka-Kwok I, Mercado P, Bean J, Monaghan M, Seymour SL, Argast GM, Epstein DM, Haley JD. 2011. A systems view of epithelial-mesenchymal transition signaling states. Clin Exp Metastasis. 28:137–155.
   PubMed Web of Science ®Google Scholar
• Tomas FM, Walton PE, Dunshea FR, Ballard FJ. 1997. IGF-I variants which bind poorly to IGF-binding proteins show more potent and prolonged hypoglycaemic action than native IGF-I in pigs and marmoset monkeys. J Endocrinol. 155:377–386.
   PubMed Web of Science ®Google Scholar
• Torres-Aleman I. 2010. Toward a comprehensive neurobiology of IGF-I. Dev Neurobiol. 70:384–396.
   PubMed Web of Science ®Google Scholar
• Urso B, Cope DL, Kalloo-Hosein HE, Hayward AC, Whitehead JP, O'Rahilly S, Siddle K. 1999. Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes. J Biol Chem. 274:30864–30873.
   PubMed Web of Science ®Google Scholar
• Vardy DA, Kari C, Lazarus GS, Jensen PJ, Zilberstein A, Plowman GD, Rodeck U. 1995. Induction of autocrine epidermal growth factor receptor ligands in human keratinocytes by insulin/insulin-like growth factor-1. J Cell Physiol. 163:257–265.
   PubMed Web of Science ®Google Scholar
• Wang PH. 2001. Roads to survival: Insulin-like growth factor-1 signaling pathways in cardiac muscle. Circ Res. 88:552–554.
   PubMed Web of Science ®Google Scholar
• Xin C, Ren S, Kleuser B, Shabahang S, Eberhardt W, Radeke H, Schafer-Korting M, Pfeilschifter J, Huwiler A. 2004. Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-beta-induced cell responses. J Biol Chem. 279:35255–35262.
   PubMed Web of Science ®Google Scholar
• Yan X, Forbes BE, McNeil KA, Baxter RC, Firth SM. 2004. Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation. J Biol Chem. 279:53232–53240.
   PubMed Web of Science ®Google Scholar
• Yan X, Payet LD, Baxter RC, Firth SM. 2009. Activity of human pregnancy insulin-like growth factor binding protein-3: Determination by reconstituting recombinant complexes. Endocrinology. 150:4968–4976.
   PubMed Web of Science ®Google Scholar